These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15786457)

  • 1. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity.
    Jokic N; Gonzalez de Aguilar JL; Pradat PF; Dupuis L; Echaniz-Laguna A; Muller A; Dubourg O; Seilhean D; Hauw JJ; Loeffler JP; Meininger V
    Ann Neurol; 2005 Apr; 57(4):553-6. PubMed ID: 15786457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of Nogo-A expression of atrophic muscle fibers in diagnosis of amyotrophic lateral sclerosis].
    Sun AP; Zhang J; Liao Q; Tang L; Fan DS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):238-41. PubMed ID: 21503119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Nogo-A in human muscle fibers is not specific for amyotrophic lateral sclerosis.
    Askanas V; Wojcik S; Engel WK
    Ann Neurol; 2007 Dec; 62(6):676-7; author reply 677. PubMed ID: 17894379
    [No Abstract]   [Full Text] [Related]  

  • 4. Muscle Nogo-A: a marker for amyotrophic lateral sclerosis or for denervation?
    Tågerud S; Libelius R; Magnusson C
    Ann Neurol; 2007 Dec; 62(6):676. PubMed ID: 17702029
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased expression of Noga-A in ALS muscle biopsies is not unique for this disease.
    Wojcik S; Engel WK; Askanas V
    Acta Myol; 2006 Dec; 25(3):116-8. PubMed ID: 17626519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis.
    Dupuis L; Gonzalez de Aguilar JL; di Scala F; Rene F; de Tapia M; Pradat PF; Lacomblez L; Seihlan D; Prinjha R; Walsh FS; Meininger V; Loeffler JP
    Neurobiol Dis; 2002 Aug; 10(3):358-65. PubMed ID: 12270696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLUT11, but not GLUT8 or GLUT12, is expressed in human skeletal muscle in a fibre type-specific pattern.
    Gaster M; Handberg A; Schürmann A; Joost HG; Beck-Nielsen H; Schrøder HD
    Pflugers Arch; 2004 Apr; 448(1):105-13. PubMed ID: 14704796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis.
    Teng FY; Tang BL
    J Cell Mol Med; 2008 Aug; 12(4):1199-204. PubMed ID: 18419791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model.
    Jokic N; Gonzalez de Aguilar JL; Dimou L; Lin S; Fergani A; Ruegg MA; Schwab ME; Dupuis L; Loeffler JP
    EMBO Rep; 2006 Nov; 7(11):1162-7. PubMed ID: 17039253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes.
    Pradat PF; Bruneteau G; Gonzalez de Aguilar JL; Dupuis L; Jokic N; Salachas F; Le Forestier N; Echaniz-Laguna A; Dubourg O; Hauw JJ; Tranchant C; Loeffler JP; Meininger V
    Ann Neurol; 2007 Jul; 62(1):15-20. PubMed ID: 17455292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial.
    Meininger V; Pradat PF; Corse A; Al-Sarraj S; Rix Brooks B; Caress JB; Cudkowicz M; Kolb SJ; Lange D; Leigh PN; Meyer T; Milleri S; Morrison KE; Orrell RW; Peters G; Rothstein JD; Shefner J; Lavrov A; Williams N; Overend P; Price J; Bates S; Bullman J; Krull D; Berges A; Abila B; Meno-Tetang G; Wurthner J
    PLoS One; 2014; 9(5):e97803. PubMed ID: 24841795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of Myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients.
    Conti A; Riva N; Pesca M; Iannaccone S; Cannistraci CV; Corbo M; Previtali SC; Quattrini A; Alessio M
    Biochim Biophys Acta; 2014 Jan; 1842(1):99-106. PubMed ID: 24184715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
    Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
    Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of cardiac ankyrin repeat protein and its homologue, ankyrin repeat protein with PEST and proline-rich region, in atrophic muscles in amyotrophic lateral sclerosis.
    Nakamura K; Nakada C; Takeuchi K; Osaki M; Shomori K; Kato S; Ohama E; Sato K; Fukayama M; Mori S; Ito H; Moriyama M
    Pathobiology; 2002-2003; 70(4):197-203. PubMed ID: 12679596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of NOGO-A protein in the human nervous system.
    Buss A; Sellhaus B; Wolmsley A; Noth J; Schwab ME; Brook GA
    Acta Neuropathol; 2005 Aug; 110(2):113-9. PubMed ID: 15616791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis.
    Atkin JD; Scott RL; West JM; Lopes E; Quah AK; Cheema SS
    Neuromuscul Disord; 2005 May; 15(5):377-88. PubMed ID: 15833433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nogo signaling and non-physical injury-induced nervous system pathology.
    Teng FY; Tang BL
    J Neurosci Res; 2005 Feb; 79(3):273-8. PubMed ID: 15619232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis.
    de Andrade HM; de Albuquerque M; Avansini SH; de S Rocha C; Dogini DB; Nucci A; Carvalho B; Lopes-Cendes I; França MC
    J Neurol Sci; 2016 Sep; 368():19-24. PubMed ID: 27538595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients.
    Harel NY; Cudkowicz ME; Brown RH; Strittmatter SM
    Biomarkers; 2009 Sep; 14(6):414-7. PubMed ID: 19548774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of Nogo-B in human carotid atherosclerotic plaques are associated with an atheromatous phenotype, restenosis, and stenosis severity.
    Rodriguez-Feo JA; Hellings WE; Verhoeven BA; Moll FL; de Kleijn DP; Prendergast J; Gao Y; van der Graaf Y; Tellides G; Sessa WC; Pasterkamp G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1354-60. PubMed ID: 17413036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.